Results
1 -
5 of
5Tam Joseph, Vemuri V. Kiran, Liu Jie, Bátkai Sándor, Mukhopadhyay Bani, Godlewski Grzegorz, Osei-Hyiaman Douglas, Ohnuma Shinobu, Ambudkar Suresh V., Pickel James, Makriyannis Alexandros, Kunos George.
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity, Journal of Clinical Investigation, 2010 Järbe Torbjörn U. C., LeMay Brian J., Vemuri V. Kiran, Vadivel Subramanian K., Zvonok Alexander, Makriyannis Alexandros.
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats, Psychopharmacology, 2011 Cluny NL, Vemuri VK, Chambers AP, Limebeer CL, Bedard H, Wood JT, Lutz B, Zimmer A, Parker LA, Makriyannis A, Sharkey KA.
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents, British Journal of Pharmacology, 2010 Randall P.A., Vemuri V.K., Segovia K.N., Torres E. Ferreris, Hosmer S., Nunes E.J., Santerre J.L., Makriyannis A., Salamone J.D..
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior, Pharmacology Biochemistry and Behavior, 2010